Acute Hepatitis C Clinical Trial
Official title:
Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study
This is an open-label, single arm, multicenter, pilot-study to compare the efficacy and safety of LDV/SOF fixed dose combination (FDC) in subjects with acute genotype 1 HCV infection. A total of 20 subjects will be assigned to receive LDV/SOF FDC tablet (LDV 90 mg/SOF 400 mg/) once daily for 6 weeks.Patients will be followed up for 24 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00755950 -
Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
|
Phase 2/Phase 3 | |
| Completed |
NCT02886624 -
Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
|
Phase 2 | |
| Completed |
NCT03818308 -
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir
|
Phase 2 | |
| Recruiting |
NCT01289652 -
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
|
N/A | |
| Completed |
NCT00959166 -
To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection
|
N/A | |
| Completed |
NCT02377856 -
Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection
|
Phase 4 | |
| Completed |
NCT02600325 -
Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
|
Phase 3 | |
| Completed |
NCT02000063 -
Australian Trial in Acute Hepatitis C Recall Study
|
N/A | |
| Completed |
NCT01336010 -
Treatment of Recently Acquired Hepatitis C Virus Infection
|
Phase 4 |